Concepedia

Xiaojian Jiang

XJ

Statistics

Publications

11

Citations

518

H-Index

11

Active since

2008

Affiliations

United States Food and Drug Administration(Current)

Center for Drug Evaluation and Research

Second Affiliated Hospital of Zhejiang University

Xian Central Hospital

Zhejiang University

Xiaojian Jiang is an author at United States Food and Drug Administration specializing in pharmacology, pharmacy, and bioavailability.

ORCID

Publications per year

2008–2025

11

Publications

11

Highly Variable Drugs: Observations from Bioequivalence Data Submitted to the FDA for New Generic Drug Applications

Barbara M. Davit, Dale P. Conner, Beth Fabian-Fritsch et al. · The AAPS Journal · 2008 · 129 citations · Full text

, , +16

LncRNA SNHG5 regulates imatinib resistance in chronic myeloid leukemia via acting as a CeRNA against MiR-205-5p.

Baoming He, Ying Bai, Wei Kang et al. · PubMed · 2017 · 91 citations

, , +17

Interleukin-17 induces pyroptosis in osteoblasts through the NLRP3 inflammasome pathway in vitro

Lihong Lei, Jianwei Sun, Jiayin Han et al. · International Immunopharmacology · 2021 · 65 citations

, , +14

3D printed bioceramic scaffolds: Adjusting pore dimension is beneficial for mandibular bone defects repair

Hongling Qin, Yingming Wei, Jiayin Han et al. · Journal of Tissue Engineering and Regenerative Medicine · 2022 · 51 citations

, , +17

Applications of In Vitro–In Vivo Correlations in Generic Drug Development: Case Studies

Paramjeet Kaur, Xiaojian Jiang, John Duan et al. · The AAPS Journal · 2015 · 44 citations · Full text

, , +16

1–5 of 11